Agilent Technologies (NYSE:A) released its quarterly earnings results on Monday. The medical research company reported $0.81 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.74 by $0.07, Bloomberg Earnings reports. The business had revenue of $1.29 billion during the quarter, compared to analyst estimates of $1.26 billion. Agilent Technologies had a net margin of 6.20% and a return on equity of 18.61%. The business’s revenue was up 8.8% on a year-over-year basis. During the same period last year, the business earned $0.67 EPS.

A stock traded down $2.38 during mid-day trading on Monday, hitting $62.61. 3,390,980 shares of the company were exchanged, compared to its average volume of 2,569,233. The firm has a market cap of $20.72 billion, a P/E ratio of 26.53, a P/E/G ratio of 2.03 and a beta of 1.35. The company has a debt-to-equity ratio of 0.39, a current ratio of 3.62 and a quick ratio of 3.00. Agilent Technologies has a twelve month low of $60.42 and a twelve month high of $75.00.

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 23rd. Shareholders of record on Monday, December 31st will be issued a dividend of $0.164 per share. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.15. This represents a $0.66 annualized dividend and a yield of 1.05%. The ex-dividend date is Friday, December 28th. Agilent Technologies’s dividend payout ratio (DPR) is currently 25.42%.

In other Agilent Technologies news, Director Paul N. Clark sold 2,876 shares of the firm’s stock in a transaction on Thursday, September 13th. The shares were sold at an average price of $68.60, for a total transaction of $197,293.60. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Heidi Fields sold 5,482 shares of the firm’s stock in a transaction on Tuesday, September 11th. The stock was sold at an average price of $67.73, for a total transaction of $371,295.86. The disclosure for this sale can be found here.

A number of equities research analysts recently weighed in on A shares. Goldman Sachs Group raised shares of Agilent Technologies from a “buy” rating to a “conviction-buy” rating in a report on Monday, September 17th. ValuEngine lowered shares of Agilent Technologies from a “buy” rating to a “hold” rating in a report on Tuesday, October 23rd. Morgan Stanley raised their price target on shares of Agilent Technologies from $84.00 to $86.00 and gave the company an “overweight” rating in a report on Wednesday, October 10th. Deutsche Bank raised their price target on shares of Agilent Technologies from $77.00 to $80.00 and gave the company a “buy” rating in a report on Wednesday, August 15th. Finally, Cleveland Research lowered shares of Agilent Technologies from a “buy” rating to a “neutral” rating in a report on Monday, November 12th. Two research analysts have rated the stock with a hold rating and nine have given a buy rating to the company. Agilent Technologies currently has an average rating of “Buy” and an average price target of $77.44.

ILLEGAL ACTIVITY WARNING: This news story was originally reported by Daily Political and is the sole property of of Daily Political. If you are reading this news story on another domain, it was stolen and republished in violation of United States and international copyright & trademark laws. The correct version of this news story can be viewed at https://www.dailypolitical.com/2018/11/19/agilent-technologies-a-posts-quarterly-earnings-results-beats-expectations-by-0-07-eps.html.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; microfluidics based automated electrophoresis products; cell analysis plate based assays; laboratory software and informatics systems; laboratory automation; dissolution testing; vacuum pumps; and measurement technologies.

Further Reading: Swap

Earnings History for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.